A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.

Trial Profile

A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Nov 2016

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2016 Status changed from recruiting to completed,according to the results presented at The Liver Meeting 2016: 67th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 07 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top